8-K filed March 17, 2026, 7:59 PM ET ticker FLGT CIK 0001674930

M&A confidence high sentiment neutral materiality 0.70

Fulgent Genetics completes acquisitions of Bako Diagnostics and StrataDx for ~$56.9M cash

Fulgent Genetics, Inc.

Total combined purchase price approximately $56.9 million in cash, subject to post-closing adjustments.
StrataDx acquired for ~$13.5M cash; Bako Diagnostics assets acquired for ~$43.4M cash.
Acquisition includes lease assignment for 29,099 sq ft lab/office in Alpharetta, GA through July 2032.
Advisors: Piper Sandler and Mintz Levin for Fulgent; EV Health Partners and Latham & Watkins for sellers.
Transaction originally announced Dec 22, 2025; closed March 17, 2026.

item 1.01 item 2.01 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001674930-26-000012
form_type: 8-K
ticker: FLGT
cik: 0001674930
company_name: Fulgent Genetics, Inc.
filed_at: 2026-03-17T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.859522+00:00
generated_at: 2026-05-15T10:31:46.132530+00:00
sec_items: ["1.01", "2.01", "7.01", "9.01"]
event_type: m_and_a
sentiment: neutral
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001674930-26-000012
json_url: https://secwatch.observer/filing/0001674930-26-000012.json
markdown_url: https://secwatch.observer/filing/0001674930-26-000012.md
text_url: https://secwatch.observer/filing/0001674930-26-000012.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1674930/000167493026000012/0001674930-26-000012-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1674930/000167493026000012/flgt-20260317.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

5230f85c2a906e0c9740474d9bdd304304082dbf

Fulgent Genetics, Inc. completed an acquisition involving Inform Diagnostics, Inc. (closed 2026-03-17).

On March 17, 2026, the transactions contemplated by the PSA were completed (the "PSA Closing").

SEC 8-K Item 2.01/5.01 confidence 0.95 SEC evidence

64368db49e0509e52482fc6d7f8e7068237eba1e

Fulgent Genetics, Inc. completed an acquisition involving Bako Pathology LP, Bako Pathology Holdings Corp., BPA Holding Corp., Bakotic Pathology Associates, L.L.C., Podceuticals L.L.C., GBRL Consulting (closed 2026-03-17).

On March 17, 2026, the transactions contemplated by the APA were completed (the "APA Closing").

SEC 8-K Item 2.01/5.01 confidence 0.95 SEC evidence

Comparable filings

APAD

Enhanced Group completes de-SPAC merger with Enhanced Ltd; redemptions of $201.7M

Enhanced Group Inc. May 8, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 5.06, 3.02, 9.01, 4.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

On March 17, 2026, the transactions contemplated by the PSA were completed (the "PSA Closing").

Comparable filing

On May 7, 2026, as contemplated by the Business Combination Agreement and as described in the section titled “ The BCA Proposal ” beginning on pa ge 180 of the Proxy Statement/Prospectus, the Company, Enhanced and Merger Sub consummated the business combination contemplated by the Business Combination Agreement, whereby: • Merger Sub merged with and into Enhanced (the “First Merger”), with Enhanced surviving the merger as a wholly owned subsidiary of the Company;

Filing page SEC filing

RMIX

Suncrete acquires Nelson Bros. Ready Mix for $42.3M cash + stock; earnout up to $18M

Suncrete, Inc. May 7, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

On March 17, 2026, the transactions contemplated by the PSA were completed (the "PSA Closing").

Comparable filing

Mr. Owens, Ms. Owens and JAO, the “Sellers”), and Jacob Owens in his capacity as representative of the Sellers. The aggregate consideration for the Acquisition consisted of (i) 1,296,456 shares of Class A Common Stock, par value $0.0001 per share, of the Company (“Class A Common Stock”) issued to the Sellers (the “Stock Consideration”) and (ii) a $42.3 million net

Filing page SEC filing

ACNT

Ascent Industries acquires Midwest Graphic/Sigma for $14M; Q1 net sales up 9% to $19.4M but adjusted EBITDA loss widens

ASCENT INDUSTRIES CO. May 6, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 2.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

On March 17, 2026, the transactions contemplated by the PSA were completed (the "PSA Closing").

Comparable filing

the Company purchased substantially all of the assets and certain specified liabilities of Seller for $14,000,000, subject to certain customary adjustments for working capital, transaction expenses, and cash, on the terms and subject to the conditions set forth in the Purchase Agreement (the “Transaction”). The Transaction closed simultaneously with the execution of the Purchase Agreement.

Filing page SEC filing

APLD

Applied Digital completes cloud business spinoff, retains ~97% of ChronoScale (CHRN)

Applied Digital Corp. May 5, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

On March 17, 2026, the transactions contemplated by the PSA were completed (the "PSA Closing").

Comparable filing

On May 5, 2026 (the “Closing Date”), Applied Digital Corporation, a Nevada corporation (the “Company”), completed the previously announced divestiture of its cloud business pursuant to that certain Contribution and Exchange Agreement

Filing page SEC filing

BKKT

Bakkt completes acquisition of DTR; issues ~11.3M shares to sellers including CEO

Bakkt, Inc. April 30, 2026, 7:59 PM ET m_and_a Items 2.01, 1.01, 3.02, 5.01, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

On March 17, 2026, the transactions contemplated by the PSA were completed (the "PSA Closing").

Comparable filing

Purchase Agreement) for purposes of consummating the acquisition of DTR at Closing. At the closing of the acquisition of DTR (the “Closing”), the Company issued an aggregate of 11,316,775 shares (such shares, the “Consideration Shares”) of its Class A Common Stock, par value $0.0001 per share (the “Class A Common Stock”), comprised of (A) 31.5% of (i) the aggregate

Filing page SEC filing

RMIX

Suncrete completes acquisition of Hope Concrete (10 plants, 88 trucks) for $39.4M + equity

Suncrete, Inc. April 29, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

On March 17, 2026, the transactions contemplated by the PSA were completed (the "PSA Closing").

Comparable filing

in its capacity as representative of the Sellers. After giving effect to the transactions contemplated by the Purchase Agreement, the aggregate consideration consisted of (i) 220,007 shares (the “Mikytuck Rollover Securities”) of Class A Common Stock, par value $0.0001 per share, of the Company (“Class A Common Stock”) issued to Mr. Mikytuck, (ii) 69,511

Filing page SEC filing

PHGE

BiomX accelerates option exercise, acquires 60% stake in DFSL for $750k cash, $3M note

BiomX Inc. April 13, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

On March 17, 2026, the transactions contemplated by the PSA were completed (the "PSA Closing").

Comparable filing

delivery. In consideration for the Purchased Shares, the Company agreed to the following consideration to Mandragola: (i) a cash payment of Seven Hundred Fifty Thousand Dollars ($750,000), of which Four Hundred Fifty Thousand ($450,000) was advanced by the Company; (ii) the issuance of an unsecured convertible promissory note in the principal amount of Three

Filing page SEC filing

PHGE

BiomX acquires ZorroNet, enters AI defense with $1.25M note and stock

BiomX Inc. April 10, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

On March 17, 2026, the transactions contemplated by the PSA were completed (the "PSA Closing").

Comparable filing

active engagements with Elbit Systems Ltd (TASE/Nasdaq: ESLT) and other top Israel’s preeminent defense prime contractors. As consideration, the Company issued to Water IO: (i) 1,300,000 shares of common stock ; and (ii) a non-convertible promissory note in the amount of $1,250,000 , bearing interest at the short-term applicable federal rate, payable July 7, 2026.

Filing page SEC filing

Source: SEC EDGAR

accession 0001674930-26-000012

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.